Levodopa-Loaded 3D-Printed Poly (Lactic) Acid/Chitosan Neural Tissue Scaffold as a Promising Drug Delivery System for the Treatment of Parkinson’s Disease

Abstract

Parkinson’s disease, the second most common neurodegenerative disease in the world, develops due to decreased dopamine levels in the basal ganglia. Levodopa, a dopamine precursor used in the treatment of Parkinson’s disease, can be used as a drug delivery system. This study presents an approach to the use of 3D-printed levodopa-loaded neural tissue scaffolds produced with polylactic acid (PLA) and chitosan (CS) for the treatment of Parkinson’s disease. Surface morphology and pore sizes were examined by scanning electron microscopy (SEM). Average pore sizes of 100–200 µm were found to be ideal for tissue engineering scaffolds, allowing cell penetration but not drastically altering the mechanical properties. It was observed that the swelling and weight loss behaviors of the scaffolds increased after the addition of CS to the PLA. Levodopa was released from the 3D-printed scaffolds in a controlled manner for 14 days, according to a Fickian diffusion mechanism. Mesenchymal stem cells (hAD-MSCs) derived from human adipose tissue were used in MTT analysis, fluorescence microscopy and SEM studies and confirmed adequate biocompatibility. Overall, the obtained results show that PLA/CS 3D-printed scaffolds have an alternative use for the levodopa delivery system for Parkinson’s disease in neural tissue engineering applications.

A Novel Strategy as a Potential Rapid Therapy Modality in the Treatment of Corneal Ulcers: Fluconazole/Vancomycin Dual Drug‐Loaded Nanofibrous Patches

“…According to the literature, materials that absorb more water and have adequate swelling capabilities demonstrate faster weight loss. [ 48 ] When the results were examined, we observed that the degradation rate decreased when the fibers were loaded with drugs.…”

“…The ranges of the “ n ” value in the literature are shown in Table 3 . [ 48 ] When the “ n ” values were evaluated, both drugs exhibited a Super‐Case‐II release mechanism according to the Korsmeyer–Peppas model. Super Case‐II represents the release mechanism of hydrophilic polymer swelling in water and biological fluids as a result of chain relaxation.…”

Manufacturing of Zinc Oxide Nanoparticle (ZnO NP)-Loaded Polyvinyl Alcohol (PVA) Nanostructured Mats Using Ginger Extract for Tissue Engineering Applications

“…The fibers were removed from the PBS medium and dried for 24 h at room temperature, weighing ( Wt ) daily for degradation testing. The deterioration index was calculated using Equation (2) [ 21 ]. …”

Role of 3D Printing in the Development of Biodegradable Implants for Central Nervous System Drug Delivery

“…25 3D-printed poly(lactic)acid and chitosan scaffolds (average pore sizes of 100−200 μm) prepared by extrusion were studied for the controlled release of levodopa (used in the treatment of Parkinson's disease) over 14 days. 115 Levodopa was released through the Fickian diffusion mechanism with different kinetic models at three different concentrations. The scaffold was also found to be safe with no toxic effects in vitro.…”